Understanding Sex Differences in Bladder Cancer
Sex, Chromosomes, and Immunity in Bladder Cancer
This research explores why bladder cancer affects men more often than women, hoping to find new ways to treat the disease based on biological differences.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11141039 on NIH RePORTER |
What this research studies
This program aims to understand why bladder cancer is 3-5 times more common in men, even when accounting for other risk factors like smoking. Researchers are bringing together experts in immunology, cancer biology, and epigenetics to uncover how sex-specific factors, such as hormones, chromosomes, and immune responses, influence bladder cancer development and progression. The ultimate goal is to identify unique biological pathways that can lead to new, personalized treatments tailored to a patient's biological sex. This involves looking closely at immune cell behavior, genetic factors, and how genes are turned on or off.
Who could benefit from this research
Good fit: Patients with bladder cancer, particularly those interested in how biological sex influences their disease and potential future treatments, would be ideal.
Not a fit: Patients whose bladder cancer is not influenced by sex-specific biological factors, or those not seeking novel, targeted therapies, may not directly benefit from this specific line of inquiry.
Why it matters
Potential benefit: If successful, this work could lead to new, more effective treatments for bladder cancer that are specifically designed based on a patient's biological sex.
How similar studies have performed: This program builds on existing collaborations and recent discoveries, suggesting a foundation in prior successful work, but the specific approach to sex-specific drivers in bladder cancer is innovative.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Xue Sean — Cedars-Sinai Medical Center
- Study coordinator: Li, Xue Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.